Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a revaluation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinary share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 4 November 2011 of an increase in the notional allocation of Ordinary share ADRs on 3 November 2011 at a price of $44.55 per ADR:-
Director/PDMR
|
Number of ADRs |
Connected Person |
Number of ADRs |
||
Dr M M Slaoui
|
9 |
Dr K Slaoui |
8 |
||
Mr W C Louv
|
15 |
- |
- |
||
Dr D Pulman
|
27 |
- |
- |
||
Mr E J Gray
|
21 |
- |
- |
||
Mrs D P Connelly
|
1 |
- |
- |
||
|
|
|
|||
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
4 November 2011